Altered effects of an A1 adenosine receptor agonist on the evoked responses of spinal dorsal horn neurones in a rat model of mononeuropathy

Journal of Pain

Volumn 1, Issue 2, 2000, Pages 99-110

  Suzuki, Rie ^a   Gale, Anabelle ^a   Dickenson, Anthony H ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Adenosine; Antinociception; CPA; Nerve injury; Spinal cord

Indexed keywords

ADENOSINE A1 RECEPTOR AGONIST; N CYCLOPENTYLADENOSINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; ELECTROPHYSIOLOGY; EVOKED BRAIN STEM RESPONSE; MALE; MONONEUROPATHY; NONHUMAN; RAT; SPINAL CORD DORSAL HORN; SPINAL CORD NERVE CELL; TREATMENT OUTCOME;

EID: 0033889656     PISSN: 15265900     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1526-5900(00)90095-6     Document Type: Article

References (59)

1. The role of purines in nociception
2. Adenosine receptor activation and nociception
3. Physiological roles for adenosine and ATP in synaptic transmission in the spinal dorsal horn
4. Adenosine A1 and A2 receptors of the substantia gelatinosa are located pre-dominantly on intrinsic neurons: An autoradiography study
5. Identification of A1 and A2 adenosine receptors in the rat spinal cord
6. Receptors for purines and pyrimidines
7. Involvement of A2 adenosine receptors in spinal mechanisms of antinociception
8. Classification of adenosine receptors mediating antinociception in the rat spinal cord
9. The roles of spinal adenosine receptors in the control of acute and more persistent nociceptive responses of dorsal horn neurones in the anaesthetized rat
10. Purines in pain management
11. Adenosine inhibition of synaptic transmission in the substantia gelatinosa
12. Spinal R-phenyl-isopropyl adenosine inhibits spinal dorsal horn neurons responding to noxious heat stimulation in the absence and presence of sensitization
13. Morphine responsiveness of chronic pain: Double-blind randomised crossover study with patient-controlled analgesia see comments
14. Lack of analgesic effect of opioids on neuropathic and idiopathic forms of pain
15. Adenosine receptor activation suppresses tactile hypersensitivity and potentiates spinal cord stimulation in mononeuropathic rats
16. Local antinociceptive and hyperalgesic effects in the formalin test after peripheral administration of adenosine analogs in mice
17. Systemic adenosine infusion: A new treatment modality to alleviate neuropathic pain
18. Pharmacology of the spinal adenosine receptor which mediates the antiallodynic action of intrathecal adenosine agonists
19. Effect of adenosine-induced changes in presynaptic release probability on long-term potentiation in the hippocampal CA1 region
20. NMDA-independent LTP by adenosine A2 receptor-mediated postsynaptic AMPA potentiation in hippocampus
21. Induction of long-term potentiation at spinal synapses by noxious stimulation or nerve injury
22. An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat
23. Ethical guidelines for investigations of experimental pain in conscious animals
24. Electrophysiological studies on the effects of intrathecal morphine on nociceptive neurones in the rat dorsal horn
25. Electrophysiological characterization of spinal neuronal response properties in anaesthetized rats after ligation of spinal nerves L5-L6
26. The distribution of m and d opioid binding sites belonging to a single cervical dorsal root in the superficial dorsal horn of the rat spinal cord: A quantitative autoradiographic study
27. The effectiveness of spinal and systemic morphine on rat dorsal horn neuronal responses in the spinal nerve ligation model of neuropathic pain
28. Adenosine-containing neurons in the brain localized by immunocytochemistry
29. Characterization and localization of adenosine receptors in rat spinal cord
30. Spinal antinociceptive effects of adenosine compounds in mice
31. Role of ATP-sensitive K+ channels in antinociception induced by R-PIA, an adenosine A1 receptor agonist
32. Intrathecal adenosine analog administration reduces substance P in cerebrospinal fluid along with behavioral effects that suggest antinociception in rats
33. Adenosine inhibits action potential-dependent release of calcitonin gene-related peptide- and substance P-like immunoreactivities from primary afferents in rat spinal cord
34. Adenosine A1 receptors mediate the presynaptic inhibition of calcitonin gene-related peptide release by adenosine in the rat spinal cord
35. Paired pulse facilitation of GABAergic IPSCs in ventral horn neurons in neonatal rat spinal cord
36. Adenosine decreases neurotransmitter release at central synapses
37. Adenosine A1 receptors mediate retinotectal presynaptic inhibition: Uncoupling by C-kinase and role in LTP during regeneration
38. Adenosine decreases aspartate and glutamate release from rat hippocampal slices
39. Presynaptic inhibition of miniature excitatory synaptic currents by baclofen and adenosine in the hippocampus
40. Modulation of inspiratory drive to phrenic motoneurons by presynaptic adenosine A1 receptors
41. Electrophysiological study on spinal antinociceptive interactions between adenosine and morphine in the dorsal horn of the rat
42. Synaptic interactions between GABA-immunoreactive profiles and the terminals of functionally defined myelinated nociceptors in the monkey and cat spinal cord
43. Synaptic interactions between primary afferent terminals and GABA and nitric oxide-synthesizing neurons in superficial laminae of the rat spinal cord
44. Decreased GABA immunoreactivity in rat dorsal horn is correlated with pain behaviour: A light and electron microcopic study
45. Loss of GABA-immunoreactivity in the spinal dorsal horn of rats with peripheral nerve injury and promotion of recovery by adrenal medullary grafts
46. The safety and efficacy of intrathecal adenosine in patients with chronic neuropathic pain
47. Pertussis toxin reverses adenosine inhibition of neuronal glutamate release
48. Low-level N-methyl-D-aspartate receptor activation provides a purinergic inhibitory threshold against further N-methyl-D-aspartate-mediated neurotransmission in the cortex
49. Intrathecal MK-801 and local nerve anesthesia synergistically reduce nociceptive behaviors in rats with experimental peripheral mononeuropathy
50. Systemic ketamine attenuates nociceptive behaviors in a rat model of peripheral neuropathy
51. Adenosine and neuropathic pain
52. Intrathecal and systemic R-phenylisopropyl-adenosine reduces scratching behaviour in a rat mononeuropathy model
53. Exogenous and endogenous adenosine enhance the spinal antiallodynic effects of morphine in a rat model of neuropathic pain
54. Intrathecal administration of the adenosine A1 receptor agonist R-phenylisopropyl adenosine reduces presumed pain behaviour in a rat model of central pain
55. Spinal pharmacology of thermal hyperesthesia induced by incomplete ligation of sciatic nerve. I. Opioid and nonopioid receptors
56. Intrathecal adenosine does not relieve allodynia-like behaviour in spinally injured rats
57. Systemic adenosine infusion alleviates spontaneous and stimulus evoked pain in patients with peripheral neuropathic pain
58. An A1-selective adenosine agonist abolishes allodynia elicited by vibration and touch after intrathecal injection
59. Effects of intrathecal injection of the adenosine receptor agonists R-phenylisopropyl-adenosine and N-ethylcarboxamide-adenosine on nociception and motor function in the rat